VIPIDIA

Found in: Austria Spain Lithuania United Kingdom

Active ingredients

#
Active Ingredient
Description
1

Alogliptin is a potent and highly selective inhibitor of DPP-4, >10,000-fold more selective for DPP-4 than other related enzymes including DPP-8 and DPP-9. Alogliptin improves glycaemic control via a glucose-dependent mechanism, whereby insulin release is enhanced and glucagon levels are suppressed when glucose levels are high.

Medicine classification

ATC Code
Title
Class
Alogliptin
A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors

Product monographs

Monograph
Type
Country

Identifiers

Authority
Identifier(s)
Centro de información online de medicamentos de la AEMPS (ES)
Identifier(s): 113844003, 113844012, 113844021
Medicines & Healthcare Products Regulatory Agency (GB)
Identifier(s): 236342, 236361, 236364, 369064, 375380, 375382, 377092, 377096, 379743, 379777, 381749, 381751, 381753
Valstybinė vaistų kontrolės tarnyba (LT)
Identifier(s): 1071474, 1071475, 1071476, 1071477, 1071478, 1071479, 1071480, 1071481, 1071482, 1071483, 1071484, 1071485, 1071486, 1071487, 1071488, 1071489, 1071490, 1071491, 1071492, 1071493, 1071494, 1071495, 1071496, 1071497, 1071498, 1071499, 1071500, 1091810, 1091811, 1091812